Literature DB >> 15798896

Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase.

P Chiarugi1, M L Taddei, G Ramponi.   

Abstract

Protein tyrosine phosphatases (PTPs) have been generally recognised as key modulators of cell proliferation, differentiation, adhesion and motility. During signalling, several PTPs undergo two posttranslational modifications that greatly affect their enzymatic activity: tyrosine phosphorylation and cysteine oxidation. Although these modifications share their reversibility depending on the intracellular environment, their effects on enzymatic activity are opposite, tyrosine phosphorylation being correlated to enzyme activation and thiol oxidation to complete inactivation. Several papers have suggested that both these modifications occur in response to the same stimuli i.e. cell proliferation induced by numerous growth factors and cytokines. Conversely, the possibility that these two regulation mechanisms act simultaneously on PTPs has not been established and very few reports investigated this dual regulation of PTPs. To underline the relevance of the question, we discuss several possibilities: (i) that tyrosine phosphorylation and cysteine oxidation of PTPs may share the same target molecules but with different kinetics; (ii) that PTP phosphorylation and oxidation may take place on different subcellular pools of the same protein and (iii) that these two modifications, although having divergent effects on enzyme activity, cooperate in the integrated and coordinated function of PTPs during receptor tyrosine kinase signalling. We believe that our perspective will open new perspectives on an ancient problem--the apparent contradiction of opposing enzymatic regulation of many PTPs--thus clarifying their role as positive or negative transducers (or both) of many extracellular stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798896     DOI: 10.1007/s00018-004-4448-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  38 in total

1.  Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients.

Authors:  Joerg Seeburger; Michael Andrew Borger; Volkmar Falk; Thomas Kuntze; Markus Czesla; Thomas Walther; Nicolas Doll; Friedrich Wilhelm Mohr
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-30       Impact factor: 4.191

2.  Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers.

Authors:  A L Klein; D J Burstow; A J Tajik; P K Zachariah; C P Taliercio; C L Taylor; K R Bailey; J B Seward
Journal:  J Am Soc Echocardiogr       Date:  1990 Jan-Feb       Impact factor: 5.251

3.  Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study.

Authors:  Ingrid Kindermann; Denise Fischer; Julia Karbach; Andreas Link; Katrin Walenta; Christine Barth; Christian Ukena; Felix Mahfoud; Volker Köllner; Michael Kindermann; Michael Böhm
Journal:  Eur J Heart Fail       Date:  2012-04       Impact factor: 15.534

4.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

Review 5.  Percutaneous edge-to-edge MitraClip therapy in the management of mitral regurgitation.

Authors:  Jason H Rogers; Olaf Franzen
Journal:  Eur Heart J       Date:  2011-05-23       Impact factor: 29.983

6.  MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Stephan Baldus; Wolfgang Schillinger; Olaf Franzen; Raffi Bekeredjian; Horst Sievert; Joachim Schofer; Karl-Heinz Kuck; Thomas Konorza; Helge Möllmann; Christoph Hehrlein; Taoufik Ouarrak; Jochen Senges; Thomas Meinertz
Journal:  Eur J Heart Fail       Date:  2012-06-08       Impact factor: 15.534

7.  Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study.

Authors:  Francesca Bursi; Andrea Barbieri; Francesco Grigioni; Letizia Reggianini; Vera Zanasi; Chiara Leuzzi; Caterina Ricci; Giulia Piovaccari; Angelo Branzi; Maria Grazia Modena
Journal:  Eur J Heart Fail       Date:  2010-03-02       Impact factor: 15.534

8.  Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function.

Authors:  Ali Ahmed; Wilbert S Aronow; Jerome L Fleg
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

9.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

Authors:  Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Journal:  JAMA       Date:  2009-04-08       Impact factor: 56.272

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

1.  Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

Authors:  Mahdieh Sadidi; Stephen I Lentz; Eva L Feldman
Journal:  Biochimie       Date:  2009-02-06       Impact factor: 4.079

2.  HD-PTP is a catalytically inactive tyrosine phosphatase due to a conserved divergence in its phosphatase domain.

Authors:  Marie-Claude Gingras; Yu Ling Zhang; Dmitri Kharitidi; Alastair J Barr; Stefan Knapp; Michel L Tremblay; Arnim Pause
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.